LifePoint, Inc. (LFPI) Stock
LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About LifePoint, Inc.
LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening. This product serves a wide array of markets, including businesses, emergency medical services (ambulances), retail pharmacies, public safety organizations, and the home healthcare sector. Established in 1992, the company was formerly known as US Drug Testing, Inc. until it adopted its current name, LifePoint, Inc., in February 1998. Its headquarters are situated in Ontario, California.
LifePoint, Inc. (LFPI) stock trades at $0.00 with a market capitalization of $31294. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.01, price-to-sales of -1.69. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, LifePoint, Inc. generates a return on equity (ROE) of -250.00%, return on capital employed of -115.19%.
Official website: www.lifepointinc.org